Pediatric Subjects With Tinea Corporis
Public ClinicalTrials.gov record NCT02227290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Double-Blind, Randomized, Vehicle-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Naftin (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.
Study identification
- NCT ID
- NCT02227290
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2014
- Primary completion
- Oct 31, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Oct 27, 2016
2014 – 2015
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigative Site#001316 | Tucson | Arizona | 85712 | — |
| Investigative Site# 0010320 | Encino | California | 91436 | — |
| Merz Investigative Site#001313 | Fremont | California | 94538 | — |
| Merz Investigative Site#001301 | San Diego | California | 92102 | — |
| Merz Investigative Site#001312 | Miami | Florida | 33144 | — |
| Merz Investigative Site#001311 | Miami | Florida | 33175 | — |
| Merz Investigative Site #001310 | Miramar | Florida | 33027 | — |
| Merz Investigative Site#001307 | Saint Joseph | Missouri | 64506 | — |
| Merz Investigative Site#001309 | Omaha | Nebraska | 68114 | — |
| Merz Investigative Site#001314 | Henderson | Nevada | 89074 | — |
| Merz Investigative Site#001126 | Raleigh | North Carolina | 27612 | — |
| Merz Investigative Site#001293 | Winston-Salem | North Carolina | 27104 | — |
| Investigative Site# 0010319 | Gresham | Oregon | 97030 | — |
| Merz Investigative Site#001097 | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02227290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2016 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02227290 live on ClinicalTrials.gov.